Money Concepts Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Money Concepts Capital's GILD Position: Q1 2026 in Review
Money Concepts Capital reduced its Gilead Sciences (GILD) stake by 7.3% in Q1 2026, selling an estimated $875K and leaving 79,857 shares worth $11.1M. The position accounts for 0.62% of the portfolio, ranked #31.
Money Concepts Capital first reported a position in GILD in Q4 2020 and has held it in 20 quarters since. The position peaked at $24.5M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Money Concepts Capital held 79,857 shares of Gilead Sciences worth $11.1M as of Q1 2026.
- Money Concepts Capital sold 6,248 Gilead Sciences shares in Q1 2026, an estimated $875K.
- Gilead Sciences made up 0.62% of Money Concepts Capital's portfolio in Q1 2026, its #31 holding.
- Money Concepts Capital first reported a position in Gilead Sciences in Q4 2020 and has held it in 20 quarters since.
- Money Concepts Capital's Gilead Sciences position peaked at $24.5M in Q4 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Money Concepts Capital's 13F filing for Q1 2026, filed 30 Apr 2026.